Fritextsökning
Innehållstyper
-
Ny strategi att behandla tuberkulos
En ökning av läkemedelsresistent tuberkulos är ett stort hinder för att behandla sjukdomen framgångsrikt. Nu har forskare funnit en molekyl som förhindrar och t...
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Forskare hittar en ny klass antibiotika
Kan bli ett genombrott mot resistenta bakterier.
-
EUR 2 million for peanut allergies
ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.
-
Dålig rapportering av läkares relation till industrin
Sverige bland de sämsta länderna, visar ny studie.
-
Xvivo till Tyskland och Texas
Göteborgsbolagets XPS-teknik för lungperfusion inför transplantation levereras till Europa och Texas, USA.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.
-
Prisas för forskning om cellers tillväxt
Får en miljon för upptäckten av mTor, som kopplats till flera typer av cancer.
-
Utökar studie
Immunicum ansöker om att få inkludera fler patienter i en pågående studie med cancervaccinet Intuvax.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Biotage is regrouping
The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.
-
Many rotor options for refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Ingen effekt av akupunktur
Att behandla ofrivillig barnlöshet orsakad av polycystiskt ovariesyndrom med akupunktur har ingen effekt visar en ny studie.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
Cate Poulsen, Qiagen
Why are you going to Scanlab and Biotech Forum?
-
Multiple rotor options in refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Studie: Bättre effekt med kombination av vektorvaccin och mRNA-vaccin
En kombination av Astra Zenecas vektorvaccin och ett mRNA-vaccin minskar risken att insjukna i covid-19 jämfört med två doser av vektorvaccinet, enligt en studi...
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Positivt från Idogen
Bolaget rapporterar positiva prekliniska resultat från sin proof-of-concept-studie.